Unit 7 lands Shire, Bayer accounts

Share this article:
Omnicom Group relationship marketing agency Unit 7 has picked up new accounts from two pharma clients, the firm's CEO Loreen Babcock told MM&M.

In July, it was named consumer agency for Shire's Daytrana attention deficit disorder patch, approved by the FDA in April and made available in pharmacies in late June. The firm will also do advertising and relationship marketing work for the launch of another undisclosed Shire brand, according to Babcock.

Unit 7 has also been awarded a global brand position and launch assignment from Bayer's diagnostics division, expected to appear in 2007.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...